Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix
Go back to Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix| AVOCENT (NASDAQ: AVCT) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $25.13 | |||
| Open | $1.29 | 52 Week Low | $9.89 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-1.04 | |||
| Volume | 11,813 | |||||

